Amylyx Pharmaceuticals Announces Publication of Data Showing Randomization to AMX0035 Prolonged Tracheostomy/Ventilation-free Survival and Reduced Occurrence of First Hospitalization

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx announced the publication of long-term prespecified analyses in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP).
Click here to view original post